Quercetin, inflammation and immunity

Nutrients

Volumn 8, Issue 3, 2016, Pages

  Li, Yao ^a   Yao, Jiaying ^a   Han, Chunyan ^a   Yang, Jiaxin ^a   Chaudhry, Maria Tabassum ^a   Wang, Shengnan ^a   Liu, Hongnan ^b,c   Yin, Yulong ^b,c  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Dietary sources; Immune function; Inflammation; Metabolism; Quercetin

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE 2; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; PROTEIN KINASE TYK2; QUERCETIN; STAT3 PROTEIN; STAT4 PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ANTIINFLAMMATORY AGENT;

ABSORPTION; ANTICARCINOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; CAPILLARY PERMEABILITY; CELL DIFFERENTIATION; CELL PROLIFERATION; DIETARY INTAKE; DOWN REGULATION; DRUG BIOAVAILABILITY; FLOW CYTOMETRY; HUMAN; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; LIPID PEROXIDATION; METABOLISM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE AGGREGATION; ADVERSE EFFECTS; ANIMAL; BIOAVAILABILITY; DIET; DIETARY REFERENCE INTAKE; DIETARY SUPPLEMENT; DRUG EFFECTS; IMMUNE SYSTEM; IMMUNOLOGY; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; DIET; DIETARY SUPPLEMENTS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTESTINAL ABSORPTION; QUERCETIN; RECOMMENDED DIETARY ALLOWANCES; TREATMENT OUTCOME;

EID: 84961238197     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8030167     Document Type: Review

References (77)

1. Davis, J.M.; Murphy, E.A.; Carmichael, M.D. Effects of the dietary flavonoid quercetin upon performance and health. Curr. Sports Med. Rep. 2009, 8, 206-213
2. Aguirre, L.; Arias, N.; Macarulla, M.T.; Gracia, A.; Portillo, M.P. Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J. 2011, 4, 189-198.
3. Fischer, C.; Speth, V.; Fleig-Eberenz, S.; Neuhaus, G. Induction of zygotic polyembryos in wheat: Influence of Auxin Polar Transport. Plant Cell 1997, 9, 1767-1780
4. Ross, J.A.; Kasum, C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002, 22, 19-34
5. Hollman, P.C.; Bijsman, M.N.; van Gameren, Y.; Cnossen, E.P.; de Vries, J.H.; Katan, M.B. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic. Res. 1999, 31, 569-573
6. Häkkinen, S.H.; Kärenlampi, S.O.; Heinonen, I.M.; Mykkänen, H.M.; Törrönen, A.R. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J. Agric. Food Chem. 1999, 47, 2274-2279
7. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 2005, 81 (Suppl. S1), 243S-255S
8. Wiczkowski, W.; Romaszko, J.; Bucinski, A.; Szawara-Nowak, D.; Honke, J.; Zielinski, H.; Piskula, M.K. Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. J. Nutr. 2008, 138, 885-888
9. Smith, C.; Lombard, K.A.; Peffley, E.B.; Liu, W. Genetic analysis of quercetin in onion (Allium cepa L.) Lady Raider. Tex. J. Agric. Natl. Resour. 2003, 16, 24-28.
10. Mitchell, A.E.; Hong, Y.J.; Koh, E.; Barrett, D.M.; Bryant, D.E.; Denison, R.F.; Kaffka, S. Ten-year comparison of the influence of organic and conventional crop management practices on the content of flavonoids in tomatoes. J. Agric. Food Chem. 2007, 55, 6154-6159
11. Petrus, K.; Schwartz, H.; Sontag, G. Analysis of flavonoids in honey by HPLC coupled with coulometric electrode array detection and electrospray ionization mass spectrometry. Anal. Bioanal. Chem. 2011, 400, 2555-2563
12. Tutelian, V.A.; Lashneva, N V. Biologically active substances of plant origin. Flavonols and flavones: Prevalence, dietary sources and consumption. Vopr. Pitan. 2013, 82, 4-22.
13. Bhagwat, S.; Haytowits, D.B.; Holden, J.M. USDA Database for the Flavonoid Content of Selected Foods, Release 3; U.S. Department of Agriculture: Beltsville, MD, USA, 2011.
14. Chun, O.K.; Chung, S.J.; Song, W.O. Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr. 2007, 137, 1244-1252
15. Sun, C.; Wang, H.; Wang, D.; Chen, Y.; Zhao, Y.; Xia, W. Using an FFQ to assess intakes of dietary flavonols and flavones among female adolescents in the Suihua area of northern China. Public Health Nutr. 2015, 18, 632-639
16. Zhang, Y.; Li, Y.; Cao, C.; Cao, J.; Chen, W.; Zhang, Y.; Wang, C.; Wang, J.; Zhang, X.; Zhao, X. Dietary flavonol and flavone intakes and their major food sources in Chinese adults. Nutr. Cancer 2010, 62, 1120-1127
17. Sampson, L.; Rimm, E.; Hollman, P.C.; de Vries, J.H.; Katan, M.B. Flavonol and flavone intakes in US health professionals. J. Am. Diet. Assoc. 2002, 102, 1414-1420
18. Nishimuro, H.; Ohnishi, H.; Sato, M.; Ohnishi-Kameyama, M.; Matsunaga, I.; Naito, S.; Ippoushi, K.; Oike, H.; Nagata, T.; Akasaka, H.; et al. Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients 2015, 7, 2345-2358
19. Somerset, S.M.; Johannot, L. Dietary flavonoid sources in Australian adults. Nutr. Cancer 2008, 60, 442-449
20. Zamora-Ros, R.; Andres-Lacueva, C.; Lamuela-Raventos, R.M.; Berenguer, T.; Jakszyn, P.; Barricarte, A.; Ardanaz, E.; Amiano, P.; Dorronsoro, M.; Larrañaga, N.; et al. Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). J. Am. Diet. Assoc. 2010, 110, 390-398
21. Scholz, S.; Williamson, G. Interactions affecting the bioavailability of dietary polyphenols in vivo. Int. J. Vitam. Nutr. Res. 2007, 77, 224-235
22. Ader, P.; Wessmann, A.; Wolffram, S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic. Biol. Med. 2000, 28, 1056-1067
23. Guo, Y.; Mah, E.; Davis, C.G.; Jalili, T.; Ferruzzi, M.G.; Chun, O.K.; Bruno, R.S. Dietary fat increases quercetin bioavailability in overweight adults. Mol. Nutr. Food Res. 2013, 57, 896-905
24. Crespy, V.; Morand, C.; Manach, C. Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal l: Umen. Am. J. Physiol. 1999, 277, G120-G126
25. Manach, C.; Morand, C.; Texier, O.; Favier, M.L.; Agullo, G.; Demigné, C.; Régérat, F.; Rémésy, C. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr. 1995, 125, 1911-1922
26. Hollman, P.C.; Katan, M.B. Absorption, metabolism and bioavailability of flavonoids. In Flavonoids in Health and Disease; Rice-Evans, C.A., Packer, L., Eds.; Marcel Dekker Inc.: New York, NY, USA, 1998; pp. 483-522.
27. Day, A.J.; Bao, Y.; Morgan, M.R.; Williamson, G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic. Biol. Med. 2000, 29, 1234-1243
28. De Boer, V.C.; Dihal, A.A.; van der Woude, H.; Arts, L.C.; Wolffram, S.; Alink, G.M.; Rietjens, I.M.; Keijer, J.; Hollman, P.C. Tissue distribution of quercetin in rats and pigs. J. Nutr. 2005, 135, 1718-1725
29. Kim, D.H.; Kim, S.Y.; Park, S.Y.; Han, M.J. Metabolism of quercetin by human intestinal bacteria and its relation to some biological activities. Biol. Pharm. Bull. 1999, 22, 749-751
30. Manach, C.; Texier, O.; Morand, C.; Crespy, V.; Régérat, F.; Demigné, C.; Rémésy, C. Comparison of the bioavailability of quercetin and catechin in rats. Free Radic. Biol. Med. 1999, 27, 1259-1266
31. Oliveira, E.J.; Watson, D.G. In vitro glucuronidation of kaempferol and quercetin by human UGT-1A9 microsomes. FEBS Lett. 2000, 471, 1-6
32. Koli, R.; Erlund, I.; Jula, A.; Marniemi, J.; Mattila, P.; Alfthan, G. Bioavailability of various polyphenols from a diet containing moderate amounts of berries. J. Agric. Food Chem. 2010, 58, 3927-3932
33. Aziz, A.A.; Edwards, C.A.; Lean, M.E.; Crozier, A. Absorption and excretion of conjugated flavonols, including quercetin-41-O-beta-glucoside and isorhamnetin-41-O-beta-glucoside by human volunteers after the consumption of onions. Free Radic. Res. 1998, 29, 257-269
34. Morand, C.; Crespy, V.; Manach, C.; Besson, C.; Demigné, C.; Rémésy, C. Plasma metabolites of quercetin and their antioxidant properties. Am. J. Physiol. 1998, 275, R212-R219
35. Boulton, D.W.; Walle, U.K.; Walle, T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J. Pharm. Pharmacol. 1998, 50, 243-249
36. Young, J.F.; Nielsen, S.E.; Haraldsdóttir, J.; Daneshvar, B.; Lauridsen, S.T.; Knuthsen, P.; Crozier, A.; Sandström, B.; Dragsted, L.O. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am. J. Clin. Nutr. 1999, 69, 87-94
37. Graefe, E.U.; Derendorf, H.; Veit, M. Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int. J. Clin. Pharmacol. Ther. 1999, 37, 219-233
38. Manach, C.; Mazur, A.; Scalbert, A. Polyphenols and prevention of cardiovascular diseases. Curr. Opin. Lipidol. 2005, 16, 77-84
39. Konrad, M.; Nieman, D.C. Evaluation of quercetin as a countermeasure to exercise-induced physiological stress. In Source Antioxidants in Sport Nutrition; Lamprecht, M., Ed.; CRC Press: Boca Raton, FL, USA, 2015; Chapter 10.
40. Moon, Y.J.; Wang, L.; DiCenzo, R.; Morris, M.E. Quercetin pharmacokinetics in humans. Biopharm. Drug Dispos. 2008, 29, 205-217
41. Walle, T.; Walle, U.K.; Halushka, P.V. Carbon dioxide is the major metabolite of quercetin in humans. J. Nutr. 2001, 131, 2648-2652
42. Harwood, M.; Danielewska-Nikiel, B.; Borzelleca, J.F.; Flamm, G.W.; Williams, G.M.; Lines, T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 2007, 45, 2179-2205
43. Read, M.A. Flavonoids: Naturally occurring anti-inflammatory agents. Am. J. Pathol. 1995, 147, 235-237
44. Orsolic, N.; Knezevic, A.H.; Sver, L.; Terzic, S.; Basic, I. Immunomodulatory and antimetastatic action of propolis and related polyphenolic compounds. J. Ethnopharmacol. 2004, 94, 307-315
45. Manjeet, K.R.; Ghosh, B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages. Int. J. Immunopharmocol. 1999, 21, 435-443.
46. Gerates, L.; Moonen, H.J.J.; Brauers, K.; Wouters, E.F.M.; Bast, A.; Hageman, G.J. Dietary flavones and flavonols are inhibitor of poly (ADP-ribose) polymerase-1 in pulmonary epithelial cells. J. Nutr. 2007, 137, 2190-2195.
47. Bureau, G.; Longpre, F.; Martinoli, M.G. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J. Neurosci. Res. 2008, 86, 403-410
48. Kim, H.P.; Mani, I.; Iversen, L.; Ziboh, V.A. Effects of naturally-occurring flavonoids and bioflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot. Essent. Fat. Acids 1998, 58, 17-24
49. Lee, K.M.; Hwang, M.K.; Lee, D.E.; Lee, K.W.; Lee, H.J. Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J. Agric. Food Chem. 2010, 58, 5815-5820
50. Endale, M.; Park, S.C.; Kim, S.; Kim, S.H.; Yang, Y.; Cho, J.Y.; Rhee, M.H. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells. Immunobiology 2013, 218, 1452-1467
51. Kempuraj, D.; Madhappan, B.; Christodoulou, S.; Boucher, W.; Cao, J.; Papadopoulou, N.; Cetrulo, C.L.; Theoharides, T.C. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br. J. Pharmacol. 2005, 145, 934-944
52. Yang, D.; Liu, X.; Liu, M.; Chi, H.; Liu, J.; Han, H. Protective effects of quercetin and taraxasterol against H2O2-induced human umbilical vein endothelial cell injury in vitro. Exp. Ther. Med. 2015, 10, 1253-1260
53. Chirumbolo, S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm. Allergy Drug Targets 2010, 9, 263-285.
54. Penissi, A.B.; Rudolph, M.I.; Piezzi, R.S. Role of mast cells in gastrointestinal mucosal defense. Biocell 2003, 27, 163-172
55. Huang, R.Y.; Yu, Y.L.; Cheng, W.C.; OuYang, C.N.; Fu, E.; Chu, C.L. Immunosuppressive effect of quercetin on dendritic cell activiation and function. J. Immunol. 2010, 184, 6815-6821
56. Nair, M.P.N.; Kandaswami, C.; Mahajan, S.; Chadha, K.C.; Chawda, R.; Nair, H.; Kumar, N.; Nair, R.E.; Schwartz, S.A. The flavonoid, quercetin, differentially regulates Th-1 (IFNg) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim. Biophys. Acta 2002, 1593, 29-36
57. Lim, H.; Kim, H.P. Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids. Planta Med. 2007, 73, 1267-1274
58. Kandere-Grzybowska, K.; Kempuraj, D.; Cao, J.; Cetrulo, C.L.; Theoharides, T.C. Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br. J. Pharmacol. 2006, 148, 208-215
59. Muthian, G.; Bright, J.J. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J. Clin. Immunol. 2004, 24, 542-552
60. Morikawa, K.; Nonaka, M.; Narahara, M.; Torii, I.; Kawaguchi, K.; Yoshikawa, T.; Kumazawa, Y.; Morikawa, S. Inhibitory effect of quercetin on carrageenan-induced inflammation in rats. Life Sci. 2003, 74, 709-721
61. Stewart, L.K.; Soileau, J.L.; Ribnicky, D.; Wang, Z.Q.; Raskin, I.; Poulev, A.; Majewski, M.; Cefalu, W.T.; Gettys, T.W. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 2008, 57, S39-S46
62. Rivera, L.; Morón, R.; Sánchez, M.; Zarzuelo, A.; Galisteo, M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 2008, 16, 2081-2087
63. Mamani-Matsuda, M.; Kauss, T.; Al-Kharrat, A.; Rambert, J.; Fawaz, F.; Thiolat, D.; Moynet, D.; Coves, S.; Malvy, D.; Mossalayi, M.D. Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem. Pharmacol. 2006, 72, 1304-1310
64. Schültke, E.; Kendall, E.; Kamencic, H.; Ghong, Z.; Griebel, R.W.; Juurlink, B.H. Quercetin promotes functional recovery following acute spinal cord injury. J. Neurotrauma 2003, 20, 583-591
65. Schültke, E.; Kamencic, H.; Skihar, V.M.; Griebel, R.; Juurlink, B. Quercetin in an animal model of spinal cord compression injury: Correlation of treatment duration with recovery of motor function. Spinal Cord 2010, 48, 112-117
66. Jung, J.H.; Kang, J.I.; Kim, H.S. Effect of quercetin on impaired immune function in mice exposed to irradiation. Nutr. Res. Pract. 2012, 6, 301-307
67. Liu, H.; Zhang, L.; Lu, S.P. Evaluation of antioxidant and immunity activities of quercetin in isoproterenol-treated rats. Molecules 2012, 17, 4281-4291
68. Dong, Y.S.; Wang, J.L.; Feng, D.Y.; Qin, H.Z.; Wen, H.; Yin, Z.M.; Gao, G.D.; Li, C. Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int. J. Med. Sci. 2014, 11, 282-290
69. Milenković, M.; Arsenović-Ranin, N.; Stojić-Vukanić, Z.; Bufan, B.; Vučićević, D.; Jančić, I. Quercetin ameliorates experimental autoimmune myocarditis in rats. J. Pharm. Pharm. Sci. 2010, 13, 311-319
70. Kobori, M.; Takahashi, Y.; Sakurai, M.; Akimoto, Y.; Tsushida, T.; Oike, H.; Ippoushi, K. Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice. Mol. Nutr. Food Res. 2016, 60, 300-312
71. Qureshi, A A.; Khan, D.A.; Mahjabeen, W.; Papasian, C.J.; Qureshi, N. Suppression of nitric oxide production and cardiovascular risk factors in healthy seniors and hypercholesterolemic subjects by a combination of polyphenols and vitamins. J. Clin. Exp. Cardiol. 2012, S5, 8.
72. Heinz, S.A.; Henson, D.A.; Austin, M.D.; Jin, F.; Nieman, D.C. Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial. Pharmacol. Res. 2010, 62, 237-242
73. Heinz, S.A.; Henson, D.A.; Nieman, D.C.; Austin, M.D.; Jin, F. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br. J. Nutr. 2010, 104, 849-857
74. Nieman, D.C.; Henson, D.A.; Gross, S.J.; Jenkins, D.P.; Davis, J.M.; Murphy, E.A.; Carmichael, M.D.; Dumke, C.L.; Utter, A.C.; McAnulty, S.R.; et al. Quercetin reduces illness but not immune perturbations after intensive exercise. Med. Sci. Sports Exerc. 2007, 39, 1561-1569
75. Henson, D.; Nieman, D.; Davis, J.M.; Dumke, C.; Gross, S.; Murphy, A.; Carmichael, M.; Jenkins, D.P.; Quindry, J.; McAnulty, S.; et al. Post-160-km race illness rates and decreases in granulocyte respiratory burst and salivary IgA output are not countered by quercetin ingestion. Int. J. Sports Med. 2008, 29, 856-863
76. Nieman, D.C.; Henson, D.A.; Maxwell, K.R.; Williams, A.S.; McAnulty, S.R.; Jin, F.; Shanely, R.A.; Lines, T.C. Effects of quercetin and EGCG on mitochondrial biogenesis and immunity. Med. Sci. Sports Exerc. 2009, 41, 1467-1475
77. Nieman, D.C.; Williams, A.S.; Shanely, R.A.; Jin, F.; McAnulty, S.R.; Triplett, N.T.; Austin, M.D.; Henson, D.A. Quercetin’s influence on exercise performance and muscle mitochondrial biogenesis. Med. Sci. Sports Exerc. 2010, 42, 338-345